therapeutic/jj
antibodies/nns
are/vbp
instrumental/jj
in/nn
improving/vbg
the/dt
treatment/nn
outcome/nn
for/in
certain/jj
disease/nn
conditions/nns
./.
however/rb
,/,
to/to
enhance/vb
their/prp$
efficacy/nn
and/cc
specificity/nn
,/,
many/jj
efforts/nns
are/vbp
continuously/rb
made/vbn
./.
one/nn
of/in
the/dt
approaches/nns
that/in
are/vbp
increasingly/rb
explored/vbn
in/nn
this/dt
field/nn
are/vbp
ph-responsive/in
antibodies/nns
capable/jj
of/in
binding/nn
target/nn
antigens/nns
in/nn
a/nn
ph-dependent/nn
manner/nn
./.
we/prp
reviewed/nn
suitability/nn
and/cc
examples/nns
of/in
these/dt
antibodies/nns
that/in
are/vbp
functionally/rb
modulated/vbn
by/in
the/dt
tumor/nn
microenvironment/nn
./.
provided/vbn
in/nn
this/dt
review/nn
is/vbz
an/dt
update/nn
about/in
antigens/nns
targeted/vbn
by/in
ph-responsive/nn
,/,
sweeping/nn
,/,
and/cc
recycling/nn
antibodies/nns
./.
applicability/nn
of/in
the/dt
ph-responsive/nn
antibodies/nns
in/nn
the/dt
engineering/vbg
of/in
chimeric/jj
antigen/nn
receptor/nn
t-cells/nns
(/(
car-t/nn
)/)
and/cc
in/nn
improving/vbg
drug/nn
delivery/nn
to/to
the/dt
brain/nn
by/in
the/dt
enhanced/vbn
crossing/in
of/in
the/dt
bloodâ€“brain/nn
barrier/nn
is/vbz
also/rb
discussed/vbn
./.
the/dt
ph-responsive/nn
antibodies/nns
possess/vbp
strong/jj
treatment/nn
potential/nn
./.
they/prp
emerge/vbp
as/in
next-generation/nn
programmable/nn
engineered/vbn
biologic/jj
drugs/nns
that/in
are/vbp
active/jj
only/rb
within/in
the/dt
targeted/vbn
biological/jj
space/nn
./.
thus/rb
,/,
they/prp
are/vbp
valuable/jj
in/nn
targeting/nn
acidified/nn
tumor/nn
microenvironment/nn
because/in
of/in
improved/jj
spatial/jj
persistence/nn
and/cc
reduced/vbd
on-target/vbn
off-tumor/in
toxicities/nns
./.
we/prp
predict/vbp
that/in
the/dt
programmable/nn
ph-dependent/nn
antibodies/nns
become/vbp
powerful/jj
tools/nns
in/nn
therapies/nns
of/in
cancer/nn
./.
